Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (12826)
All Articles published online
|
Publishing Process of This Article
|
Jan 28, 2014 (publication date) through Nov 30, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Coppedè F, Lopomo A, Spisni R, Migliore L. Genetic and epigenetic biomarkers for diagnosis, prognosis and treatment of colorectal cancer. World J Gastroenterol 2014; 20(4): 943-956 [PMID: 24574767 DOI: 10.3748/wjg.v20.i4.943] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i4/943.htm |
| Number | Citing Articles |
| 1 |
Fang Qian, Qiang Li, Huidan Chang, Kai Wei, Xiaoyi Chen, Tao Huang, Yixue Li. Identification of DNA methylation characteristics associated with metastasis and prognosis in colorectal cancer. BMC Medical Genomics 2024; 17(1) doi: 10.1186/s12920-024-01898-4
|
| 2 |
Yuna Guo, Jessica L. Ayers, Kelly T. Carter, Ting Wang, Sean K. Maden, Darwin Edmond, Polly Newcomb P, Christopher Li, Cornelia Ulrich, Ming Yu, William M. Grady. Senescence‐associated tissue microenvironment promotes colon cancer formation through the secretory factor GDF15. Aging Cell 2019; 18(6) doi: 10.1111/acel.13013
|
| 3 |
Kseniia Tumanova, Stefano Serra, Anamitra Majumdar, Jigar Lad, Fayez Quereshy, Mohammadali Khorasani, Alex Vitkin. Mueller matrix polarization parameters correlate with local recurrence in patients with stage III colorectal cancer. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-40480-3
|
| 4 |
Xin-yu Li, Lei Hou, Lu-yu Zhang, Liming Zhang, Deming Wang, Zhenfeng Wang, Ming-Zhe Wen, Xi-tao Yang. OAS3 is a Co-Immune Biomarker Associated With Tumour Microenvironment, Disease Staging, Prognosis, and Treatment Response in Multiple Cancer Types. Frontiers in Cell and Developmental Biology 2022; 10 doi: 10.3389/fcell.2022.815480
|
| 5 |
Oscar Murcia, Miriam Juárez, Eva Hernández-Illán, Cecilia Egoavil, Mar Giner-Calabuig, María Rodríguez-Soler, Rodrigo Jover. Serrated colorectal cancer: Molecular classification, prognosis, and response to chemotherapy. World Journal of Gastroenterology 2016; 22(13): 3516-3530 doi: 10.3748/wjg.v22.i13.3516
|
| 6 |
Xuan Yang, Wangao Wei, Shisheng Tan, Linrui Guo, Song Qiao, Biao Yao, Zi Wang. Identification and verification of HCAR3 and INSL5 as new potential therapeutic targets of colorectal cancer. World Journal of Surgical Oncology 2021; 19(1) doi: 10.1186/s12957-021-02335-x
|
| 7 |
JIAN GONG, JIRONG HUO. New insights into the mechanism of F-box proteins in colorectal cancer (Review). Oncology Reports 2015; 33(5): 2113 doi: 10.3892/or.2015.3823
|
| 8 |
Stefanie Lapp, Vanessa Pfankuche, Wolfgang Baumgärtner, Christina Puff. Viral Oncolysis — Can Insights from Measles Be Transferred to Canine Distemper Virus?. Viruses 2014; 6(6): 2340 doi: 10.3390/v6062340
|
| 9 |
Fundamentals of Cancer Detection, Treatment, and Prevention. 2022; : 193 doi: 10.1002/9783527838561.ch7
|
| 10 |
Ebrahim Rahmani Moghadam, Hui Li Ang, Sholeh Etehad Asnaf, Amirhossein Zabolian, Hossein Saleki, Mohammad Yavari, Hossein Esmaeili, Ali Zarrabi, Milad Ashrafizadeh, Alan Prem Kumar. Broad-Spectrum Preclinical Antitumor Activity of Chrysin: Current Trends and Future Perspectives. Biomolecules 2020; 10(10): 1374 doi: 10.3390/biom10101374
|
| 11 |
Pey Yee Lee, Siok-Fong Chin, Teck Yew Low, Rahman Jamal. Probing the colorectal cancer proteome for biomarkers: Current status and perspectives. Journal of Proteomics 2018; 187: 93 doi: 10.1016/j.jprot.2018.06.014
|
| 12 |
Bin-Liang Huang, Lai-Feng Wei, Yi-Wei Lin, Li-Sheng Huang, Qi-Qi Qu, Xin-Hao Li, Ling-Yu Chu, Yi-Wei Xu, Wei-Dong Wang, Yu-Hui Peng, Fang-Cai Wu. Serum IGFBP-1 as a promising diagnostic and prognostic biomarker for colorectal cancer. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-52220-2
|
| 13 |
Xiao-Bo Ma, Yuan-Yuan Xu, Meng-Xuan Zhu, Lu Wang. Prognostic Signatures Based on Thirteen Immune-Related Genes in Colorectal Cancer. Frontiers in Oncology 2021; 10 doi: 10.3389/fonc.2020.591739
|
| 14 |
Youyi Dai, Huaxin Duan, Chaojun Duan, Rongrong Zhou, Yuxiang He, Qingsong Tu, Liangfang Shen. Down-regulation of TCF21 by hypermethylation induces cell proliferation, migration and invasion in colorectal cancer. Biochemical and Biophysical Research Communications 2016; 469(3): 430 doi: 10.1016/j.bbrc.2015.09.109
|
| 15 |
Liqun Yang, Qian Lei, Lin Li, Jie Yang, Zhen Dong, Hongjuan Cui. Silencing or inhibition of H3K79 methyltransferase DOT1L induces cell cycle arrest by epigenetically modulating c-Myc expression in colorectal cancer. Clinical Epigenetics 2019; 11(1) doi: 10.1186/s13148-019-0778-y
|
| 16 |
Hua Ye, Wende Li, Kefeng Wu, Yi Liu, Yingnian Lv, Yuzhen Zhu, Hui Luo, Liao Cui. <p>The SP1-Induced Long Noncoding RNA, LINC00339, Promotes Tumorigenesis in Colorectal Cancer via the miR-378a-3p/MED19 Axis</p>. OncoTargets and Therapy 2020; : 11711 doi: 10.2147/OTT.S277254
|
| 17 |
Bao‑Hong Cui, Xuan Hong. miR‑6852 serves as a prognostic biomarker in colorectal cancer and inhibits tumor growth and metastasis by targeting TCF7. Experimental and Therapeutic Medicine 2018; doi: 10.3892/etm.2018.6259
|
| 18 |
Siyu Zhang, Mingrong Yu, Dan Chen, Peidong Li, Bin Tang, Jie Li. Role of MRI‑based radiomics in locally advanced rectal cancer (Review). Oncology Reports 2021; 47(2) doi: 10.3892/or.2021.8245
|
| 19 |
McKale Montgomery, Aishwarya Srinivasan. Epigenetic Gene Regulation by Dietary Compounds in Cancer Prevention. Advances in Nutrition 2019; 10(6): 1012 doi: 10.1093/advances/nmz046
|
| 20 |
Eric Van Cutsem, Caroline Paccard, Marielle Chiron, Josep Tabernero. Impact of Prior Bevacizumab Treatment on VEGF-A and PlGF Levels and Outcome Following Second-Line Aflibercept Treatment: Biomarker Post Hoc Analysis of the VELOUR Trial. Clinical Cancer Research 2020; 26(3): 717 doi: 10.1158/1078-0432.CCR-19-1985
|
| 21 |
Sidra Asghar, Walifa Waqar, Muhammad Umar, Sobia Manzoor. Tumor educated platelets, a promising source for early detection of hepatocellular carcinoma: Liquid biopsy an alternative approach to tissue biopsy. Clinics and Research in Hepatology and Gastroenterology 2020; 44(6): 836 doi: 10.1016/j.clinre.2020.03.023
|
| 22 |
Vinit Singh Baghel, Sapnita Shinde, Vibha Sinha, Vineeta Dixit, Atul Kumar Tiwari, Saurabh Saxena, Naveen Kumar Vishvakarma, Dhananjay Shukla, Prashant Bhatt. Transcription and Translation in Health and Disease. 2023; : 287 doi: 10.1016/B978-0-323-99521-4.00007-6
|
| 23 |
Wael M. Abdel-Rahman, Johanna E. Lotsari-Salomaa, Sippy Kaur, Anni Niskakoski, Sakari Knuutila, Heikki Järvinen, Jukka-Pekka Mecklin, Päivi Peltomäki. The Role of Chromosomal Instability and Epigenetics in Colorectal Cancers Lackingβ-Catenin/TCF Regulated Transcription. Gastroenterology Research and Practice 2016; 2016: 1 doi: 10.1155/2016/6089658
|
| 24 |
Cary B. Aarons, Najjia N. Mahmoud. The ASCRS Textbook of Colon and Rectal Surgery. 2016; : 433 doi: 10.1007/978-3-319-25970-3_25
|
| 25 |
Om Saswat Sahoo, Karthikeyan Pethusamy, Tryambak P. Srivastava, Joyeeta Talukdar, Mohammed S. Alqahtani, Mohamed Abbas, Ruby Dhar, Subhradip Karmakar. The metabolic addiction of cancer stem cells. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.955892
|
| 26 |
Arpana Parihar, Shivani Malviya, Raju Khan. Cancer Bioinformatics. Biomedical Engineering 2022; 12 doi: 10.5772/intechopen.101432
|
| 27 |
Yudith Annisa Ayu Rezkitha, Nur Syahadati Retno Panenggak, Maria Inge Lusida, Raissa Virgy Rianda, Isna Mahmudah, Aditya Doni Pradana, Tomohisa Uchida, Muhammad Miftahussurur. Detecting colorectal cancer using genetic and epigenetic biomarkers: screening and diagnosis. Journal of Medicine and Life 2024; 17(1): 4 doi: 10.25122/jml-2023-0269
|
| 28 |
Humzah Postwala, Yesha Shah, Priyajeet S. Parekh, Mehul R. Chorawala. Unveiling the genetic and epigenetic landscape of colorectal cancer: new insights into pathogenic pathways. Medical Oncology 2023; 40(11) doi: 10.1007/s12032-023-02201-8
|
| 29 |
Zahra Shakib, Asma Mahmoudi, Seyedeh Alia Moosavian, Bizhan Malaekeh-Nikouei. PEGylated solid lipid nanoparticles functionalized by aptamer for targeted delivery of docetaxel in mice bearing C26 tumor. Drug Development and Industrial Pharmacy 2022; 48(2): 69 doi: 10.1080/03639045.2022.2095398
|
| 30 |
Zoran Gatalica, Semir Vranic, Joanne Xiu, Jeffrey Swensen, Sandeep Reddy. High microsatellite instability (MSI-H) colorectal carcinoma: a brief review of predictive biomarkers in the era of personalized medicine. Familial Cancer 2016; 15(3): 405 doi: 10.1007/s10689-016-9884-6
|
| 31 |
Clinical significance of SPOP and APC gene alterations in colorectal cancer in Indian population. Molecular Genetics and Genomics 2023; 298(5): 1087 doi: 10.1007/s00438-023-02029-x
|
| 32 |
Yueh-Ming Lin, Chih-I Chen, Yi-Ping Hsiang, Yung-Chia Hsu, Kung-Chuan Cheng, Pei-Hsuan Chien, Hsiao-Lin Pan, Chien-Chang Lu, Yun-Ju Chen. Chrysin Attenuates Cell Viability of Human Colorectal Cancer Cells through Autophagy Induction Unlike 5-Fluorouracil/Oxaliplatin. International Journal of Molecular Sciences 2018; 19(6): 1763 doi: 10.3390/ijms19061763
|
| 33 |
|
| 34 |
Jigar Lad, Stefano Serra, Fayez Quereshy, Mohammadali Khorasani, Alex Vitkin. Polarimetric biomarkers of peri-tumoral stroma can correlate with 5-year survival in patients with left-sided colorectal cancer. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-16178-3
|
| 35 |
Xingbao Fang, Yongping Xu, Kezhi Li, Peiwan Liu, Hong Zhang, Yang Jiang, Jianwei Tang, Yuehong Li, Fu Wang. Exosomal lncRNA PCAT1 Promotes Tumor Circulating Cell-Mediated Colorectal Cancer Liver Metastasis by Regulating the Activity of the miR-329-3p/Netrin-1-CD146 Complex. Journal of Immunology Research 2022; 2022: 1 doi: 10.1155/2022/9916228
|
| 36 |
Henriette Kirchner, Hendrik Lehnert. Epigenetik – Grundlagen und klinische Bedeutung. 2018; : 25 doi: 10.1007/978-3-662-54023-7_2
|
| 37 |
Najjia N. Mahmoud. Colorectal Cancer. Surgical Oncology Clinics of North America 2022; 31(2): 127 doi: 10.1016/j.soc.2021.12.001
|
| 38 |
Angela Lopomo, Fabio Coppedè. Epigenetic Mechanisms in Cancer. 2018; : 313 doi: 10.1016/B978-0-12-809552-2.00012-7
|
| 39 |
Seyed Mostafa Parizadeh, Reza Jafarzadeh‐Esfehani, Danial Fazilat‐Panah, Seyed Mahdi Hassanian, Soodabeh Shahidsales, Majid Khazaei, Seyed Mohammad Reza Parizadeh, Majid Ghayour‐Mobarhan, Gordon A. Ferns, Amir Avan. The potential therapeutic and prognostic impacts of the c‐MET/HGF signaling pathway in colorectal cancer. IUBMB Life 2019; 71(7): 802 doi: 10.1002/iub.2063
|
| 40 |
Jin Huang, Jia-You Luo, Hong-Zhuan Tan, Ludmila Vodickova. Associations of MGMT promoter hypermethylation with squamous intraepithelial lesion and cervical carcinoma: A meta-analysis. PLOS ONE 2019; 14(10): e0222772 doi: 10.1371/journal.pone.0222772
|
| 41 |
M Alizade Naini, P Mokarram, S Kavousipour, N Zare, A Atapour, M Hassan Zarin, G Mehrabani, M Borji. Sensitive and Noninvasive Detection of Aberrant SFRP2 and MGMT-B Methylation in Iranian Patients with Colon Polyps. Asian Pacific Journal of Cancer Prevention 2016; 17(4): 2185 doi: 10.7314/APJCP.2016.17.4.2185
|
| 42 |
Tao Feng, Yanli Zhao. Nanomaterial-Based Drug Delivery Carriers for Cancer Therapy. SpringerBriefs in Applied Sciences and Technology 2017; : 1 doi: 10.1007/978-981-10-3299-8_1
|
| 43 |
Kha Wai Hon, Syafiq Asnawi Zainal Abidin, Iekhsan Othman, Rakesh Naidu. The Crosstalk Between Signaling Pathways and Cancer Metabolism in Colorectal Cancer. Frontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.768861
|
| 44 |
Seyed Mostafa Parizadeh, Reza Jafarzadeh-Esfehani, Maryam Ghandehari, Afsaneh Rezaei-Kalat, Seyed Mohammad Reza Parizadeh, Afsane Javanbakht, Seyed Mahdi Hassanian, Gordon A. Ferns, Majid Khazaei, Amir Avan. Personalized Peptide-based Vaccination for Treatment of Colorectal Cancer: Rational and Progress. Current Drug Targets 2019; 20(14): 1486 doi: 10.2174/1389450120666190619121658
|
| 45 |
Mehran Pashirzad, Reihaneh Khorasanian, Maryam Mahmoudi Fard, Mohammad-Hassan Arjmand , Hadis Langari, Majid Khazaei, Saman Soleimanpour, Majid Rezayi, Gordon A. Ferns, Seyed Mahdi Hassanian, Amir Avan. The Therapeutic Potential of MAPK/ERK Inhibitors in the Treatment of Colorectal Cancer. Current Cancer Drug Targets 2021; 21(11): 932 doi: 10.2174/1568009621666211103113339
|
| 46 |
Teodora Costea, Ariana Hudiță, Oana-Alina Ciolac, Bianca Gălățeanu, Octav Ginghină, Marieta Costache, Constanța Ganea, Maria-Magdalena Mocanu. Chemoprevention of Colorectal Cancer by Dietary Compounds. International Journal of Molecular Sciences 2018; 19(12): 3787 doi: 10.3390/ijms19123787
|
| 47 |
Hui-Min Chen, Jing-Yuan Fang. Epigenetic Biomarkers for the Early Detection of Gastrointestinal Cancer. Gastrointestinal Tumors 2014; 1(4): 201 doi: 10.1159/000380784
|
| 48 |
Weiyu Feng, Baodong Li, Jinbang Wang, Huiliang Zhang, Yonggang Liu, Dongli Xu, Ke Cheng, Jing Zhuang. Long Non-coding RNA LINC00115 Contributes to the Progression of Colorectal Cancer by Targeting miR-489-3p via the PI3K/AKT/mTOR Pathway. Frontiers in Genetics 2020; 11 doi: 10.3389/fgene.2020.567630
|
| 49 |
Pedro Costa-Pinheiro, Diana Montezuma, Rui Henrique, Carmen Jerónimo. Diagnostic and Prognostic Epigenetic Biomarkers in Cancer. Epigenomics 2015; 7(6): 1003 doi: 10.2217/epi.15.56
|
| 50 |
Yanyan Xu, Qiaoyu Xu, Yanhui Ma, Jianghui Duan, Haibo Zhang, Tongxi Liu, Lu Li, Hongliang Sun, Kaining Shi, Sheng Xie, Wu Wang. Characterizing MRI features of rectal cancers with different KRAS status. BMC Cancer 2019; 19(1) doi: 10.1186/s12885-019-6341-6
|
| 51 |
K. Sri Manjari, Srilekha Avvari, Imran Ali Khan, DKV Prasad. Role of MicroRNAs in Cancers. 2022; : 13 doi: 10.1007/978-981-16-9186-7_2
|
| 52 |
Adriana Abigail Ruiz-Quinga, Vicente Rubén Noriega-Puga. Evaluation of Epigenetic Markers in the Diagnosis and Prognosis of Colorectal Cancer. Salud, Ciencia y Tecnología 2025; 5: 1139 doi: 10.56294/saludcyt20251139
|
| 53 |
Mengdi Qin, Qiang Liu, Wei Yang, Qiaofeng Wang, Zheng Xiang. IGFL2‐AS1‐induced suppression of HIF‐1α degradation promotes cell proliferation and invasion in colorectal cancer by upregulating CA9. Cancer Medicine 2023; 12(7): 8415 doi: 10.1002/cam4.5562
|
| 54 |
Tengqi Wang, Haibin Sun, Yinshengboer Bao, Riletu En, Yongjing Tian, Wei Zhao, Lizhou Jia. POM121 overexpression is related to a poor prognosis in colorectal cancer. Expert Review of Molecular Diagnostics 2020; 20(3): 345 doi: 10.1080/14737159.2020.1707670
|
| 55 |
Szu-Yuan Wu, Kuan-Chou Lin, Bashir Lawal, Alexander T.H Wu, Ching-Zong Wu. MXD3 as an onco-immunological biomarker encompassing the tumor microenvironment, disease staging, prognoses, and therapeutic responses in multiple cancer types. Computational and Structural Biotechnology Journal 2021; 19: 4970 doi: 10.1016/j.csbj.2021.08.047
|
| 56 |
Fengjing Jia, Qun Yu, Ling Zhao, Yunhui Shen, Haidong Guo, Feng He. Sodium New Houttuyfonate Inhibits Cancer-Promoting Fusobacterium nucleatum (Fn) to Reduce Colorectal Cancer Progression. Cancers 2022; 14(24): 6111 doi: 10.3390/cancers14246111
|
| 57 |
J.S. Thomas, Chanjuan Shi. Diagnostic Molecular Pathology. 2017; : 305 doi: 10.1016/B978-0-12-800886-7.00024-8
|
| 58 |
Amir Mehrgou, Shahram Teimourian, Eduardo Andrés-León. Update of gene expression/methylation and MiRNA profiling in colorectal cancer; application in diagnosis, prognosis, and targeted therapy. PLOS ONE 2022; 17(3): e0265527 doi: 10.1371/journal.pone.0265527
|
| 59 |
Sonal Panchal, Nakul Kumar, Pankaj Kumar, Snigdha Singh, Virendra Kumar Yadav. Biomarkers in Environmental and Human Health Biomonitoring. 2024; : 269 doi: 10.1016/B978-0-443-13860-7.00011-2
|
| 60 |
Camelia Abdel-Malak, Hossam Darwish, Afaf Elsaid, Fatma El-Tarapely, Rami Elshazli. Association of APC I1307K and E1317Q polymorphisms with colorectal cancer among Egyptian subjects. Familial Cancer 2016; 15(1): 49 doi: 10.1007/s10689-015-9834-8
|
| 61 |
Giovanna Del Vecchio Blanco, Omero Alessandro Paoluzi, Pierpaolo Sileri, Piero Rossi, Giuseppe Sica, Francesco Pallone. Familial colorectal cancer screening: When and what to do?. World Journal of Gastroenterology 2015; 21(26): 7944-7953 doi: 10.3748/wjg.v21.i26.7944
|
| 62 |
Quanying Li, Hongna Tang, Fangfang Hu, Changjiang Qin. Silencing of FOXO6 inhibits the proliferation, invasion, and glycolysis in colorectal cancer cells. Journal of Cellular Biochemistry 2019; 120(3): 3853 doi: 10.1002/jcb.27667
|
| 63 |
José Antonio Fagundes Assumpção, Kelly Grace Magalhães, José Raimundo Corrêa. The role of pparγ and autophagy in ros production, lipid droplets biogenesis and its involvement with colorectal cancer cells modulation. Cancer Cell International 2017; 17(1) doi: 10.1186/s12935-017-0451-5
|
| 64 |
Kartz Bibb, Ritikraj Arya, Sabita N. Saldanha. Epigenetic Mechanisms in Cancer. 2018; : 345 doi: 10.1016/B978-0-12-809552-2.00013-9
|
| 65 |
Yang Xi, Zhuang Jing, Wu Wei, Zhang Chun, Qi Quan, Zhou Qing, Xu Jiamin, Han Shuwen. Inhibitory effect of sodium butyrate on colorectal cancer cells and construction of the related molecular network. BMC Cancer 2021; 21(1) doi: 10.1186/s12885-021-07845-1
|
| 66 |
Bokyung Ahn, Yang Seok Chae, Soo Kyung Lee, Moa Kim, Hyeon Soo Kim, Ji Wook Moon, Sun-Hwa Park. Identification of novel DNA hypermethylation of the adenylate kinase 5 promoter in colorectal adenocarcinoma. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-92147-6
|
| 67 |
Yuemei Cheng, Yijuan Xing, Junhong Du, Dan Hu, Xiaolei Liang, Chang Liu, Yongxiu Yang. Data‐independent acquisition for proteomic applications in early‐stage endometrial cancer progression. Journal of Obstetrics and Gynaecology Research 2024; 50(2): 233 doi: 10.1111/jog.15834
|
| 68 |
Siyu He, Chenglin Zhou, Hailin Peng, Mei Lin. Recent Advances in Fecal Gene Detection for Colorectal Cancer Diagnosis. Biomarkers in Medicine 2021; 15(14): 1299 doi: 10.2217/bmm-2021-0269
|
| 69 |
Yanyan Xu, Qiaoyu Xu, Hongliang Sun, Tongxi Liu, Kaining Shi, Wu Wang. Could IVIM and ADC help in predicting the KRAS status in patients with rectal cancer?. European Radiology 2018; 28(7): 3059 doi: 10.1007/s00330-018-5329-y
|
| 70 |
Bradley J. Smith, Licia C. Silva-Costa, Daniel Martins-de-Souza. Human disease biomarker panels through systems biology. Biophysical Reviews 2021; 13(6): 1179 doi: 10.1007/s12551-021-00849-y
|
| 71 |
Boram Choi, Yoojin Na, Min Yeop Whang, Jung Yoon Ho, Mi-Ryung Han, Seong-Woo Park, Heekyoung Song, Soo Young Hur, Youn Jin Choi. MGMT Methylation Is Associated with Human Papillomavirus Infection in Cervical Dysplasia: A Longitudinal Study. Journal of Clinical Medicine 2023; 12(19): 6188 doi: 10.3390/jcm12196188
|
| 72 |
Yan-min Liu, Tie-cheng Yang, Xiao-chang Fang, Li-jie Yang, Li-wen Shi, Hua-qiao Wang, Ting-ting Dou, Lin Shu, Tian-Liang Chen, Jun Hu, Xiao-ming Yu, Xuan-fei Li. Identification and Validation of SLC9A2 as A Potential Tumor Suppressor in Colorectal Cancer: Integrating Bioinformatics Analysis with Experimental Confirmation. Current Medical Science 2024; 44(3): 529 doi: 10.1007/s11596-024-2871-5
|
| 73 |
Ha Nguyen, Hong‑Quan Duong. The molecular characteristics of colorectal cancer: Implications for diagnosis and therapy (Review). Oncology Letters 2018; doi: 10.3892/ol.2018.8679
|
| 74 |
Parisa Aghagolzadeh, Ramin Radpour. New trends in molecular and cellular biomarker discovery for colorectal cancer. World Journal of Gastroenterology 2016; 22(25): 5678-5693 doi: 10.3748/wjg.v22.i25.5678
|
| 75 |
Guilherme Jeremias, Fernando J. M. Gonçalves, Joana L. Pereira, Jana Asselman. Prospects for incorporation of epigenetic biomarkers in human health and environmental risk assessment of chemicals. Biological Reviews 2020; 95(3): 822 doi: 10.1111/brv.12589
|
| 76 |
Angela Lopomo, Fabio Coppedè. Pharmacoepigenetics and pharmacoepigenomics of gastrointestinal cancers. Expert Review of Gastroenterology & Hepatology 2018; 12(1): 49 doi: 10.1080/17474124.2017.1374853
|
| 77 |
Jia Zang, Juanjuan Sun, WenChao Xiu, Xiaoshuang Liu, Yunsheng Chai, Yanyan Zhou. Low Expression of AGPAT5 Is Associated With Clinical Stage and Poor Prognosis in Colorectal Cancer and Contributes to Tumour Progression. Clinical Medicine Insights: Oncology 2022; 16 doi: 10.1177/11795549221137399
|
| 78 |
Junhui Yu, Kui Yang, Jianbao Zheng, Wei Zhao, Xuejun Sun. Synergistic tumor inhibition of colon cancer cells by nitazoxanide and obeticholic acid, a farnesoid X receptor ligand. Cancer Gene Therapy 2021; 28(6): 590 doi: 10.1038/s41417-020-00239-8
|
| 79 |
Byungho Lim, Jihyeob Mun, Seon-Young Kim. Intrinsic Molecular Processes: Impact on Mutagenesis. Trends in Cancer 2017; 3(5): 357 doi: 10.1016/j.trecan.2017.03.009
|
| 80 |
Xiao Xie, Huajiang Lin, Xiaolei Zhang, Pengtao Song, Xiangyi He, Jing Zhong, Jiemin Shi. Overexpression of GDP dissociation inhibitor 1 gene associates with the invasiveness and poor outcomes of colorectal cancer. Bioengineered 2021; 12(1): 5595 doi: 10.1080/21655979.2021.1967031
|
| 81 |
Pablo A Bejarano, Monica T Garcia-Buitrago, Mariana Berho, Daniela Allende. Biologic and molecular markers for staging colon carcinoma. Colorectal Cancer 2016; 5(1): 41 doi: 10.2217/crc.15.27
|
| 82 |
Suneetha Nunna, Ying-Pei Huang, Mahdi Rasa, Anna Krepelova, Francesco Annunziata, Lisa Adam, Sandra Käppel, Ming-Hua Hsu, Francesco Neri. Characterization of Novel α-Mangostin and Paeonol Derivatives With Cancer-Selective Cytotoxicity. Molecular Cancer Therapeutics 2022; 21(2): 257 doi: 10.1158/1535-7163.MCT-20-0787
|
| 83 |
José Luis Venegas-Rodríguez, Jesús Arturo Hernández-Sandoval, Melva Gutiérrez-Angulo, José Miguel Moreno-Ortiz, Anahí González-Mercado, Jorge Peregrina-Sandoval, Helen Haydee Fernanda Ramírez-Plascencia, Beatriz Armida Flores-López, Carlos Rogelio Alvizo-Rodríguez, Jesús Alonso Valenzuela-Pérez, Sergio Cervantes-Ortiz, María de la Luz Ayala-Madrigal. KRAS Exon 2 Mutations in Patients with Sporadic Colorectal Cancer: Prevalence Variations in Mexican and Latin American Populations. Cancers 2024; 16(13): 2323 doi: 10.3390/cancers16132323
|
| 84 |
Rachael J. Werner, Andrew D. Kelly, Jean-Pierre J. Issa. Epigenetics and Precision Oncology. The Cancer Journal 2017; 23(5): 262 doi: 10.1097/PPO.0000000000000281
|
| 85 |
Christine Ladd-Acosta, M Daniele Fallin. The Role of Epigenetics in Genetic and Environmental Epidemiology. Epigenomics 2016; 8(2): 271 doi: 10.2217/epi.15.102
|
| 86 |
Edgars Zellans, Agnese Ozolina, Ilze Lace, Eva Strike, Marite Daukste, Romans Lacis. Impact of Preoperative Anaemia on Outcome in Elective On-Pump Cardiac Surgery. Acta Chirurgica Latviensis 2014; 14(2): 3 doi: 10.1515/chilat-2015-0001
|
| 87 |
Sedigheh Rezayi, Morvarid Siri, Nasim Rahmani-Kukia, Mozhdeh Zamani, Sanaz Dastghaib, Pooneh Mokarram. The modulation of autophagy and unfolded protein response by ent-kaurenoid derivative CPUK02 in human colorectal cancer cells. Molecular Biology Reports 2024; 51(1) doi: 10.1007/s11033-024-09541-2
|
| 88 |
Jaya Bagaria, Kyung-Ok Kim, Eva Bagyinszky, Seong Soo A. An, Jeong-Heum Baek. Discriminating Potential Genetic Markers for Complete Response and Non-Complete Response Patients to Neoadjuvant Chemotherapy with Locally Advanced Rectal Cancer. International Journal of Environmental Research and Public Health 2022; 19(7): 4008 doi: 10.3390/ijerph19074008
|
| 89 |
Bhoj Raj Adhikari, Koki Yoshida, Durga Paudel, Tetsuro Morikawa, Osamu Uehara, Jun Sato, Malsantha Muthumala, Prasad Amaratunga, Toshiya Arakawa, Itsuo Chiba, Yoshihiro Abiko. Aberrant expression of DUSP4 is a specific phenomenon in betel quid-related oral cancer. Medical Molecular Morphology 2021; 54(2): 79 doi: 10.1007/s00795-020-00265-3
|
| 90 |
Fabio Coppedè. The role of epigenetics in colorectal cancer. Expert Review of Gastroenterology & Hepatology 2014; 8(8): 935 doi: 10.1586/17474124.2014.924397
|
| 91 |
Haoming Tang, Yi Xin Li, Jun Jie Lian, Hsin-Yueh Ng, Samuel Sherng Young Wang. Personalized treatment using predictive biomarkers in solid organ malignancies: A review. Tumori Journal 2024; 110(5): 386 doi: 10.1177/03008916241261484
|
| 92 |
Carolina Meloni Vicente, Daiana Aparecida da Silva, Priscila Veronica Sartorio, Tiago Donizetti Silva, Sarhan Sydney Saad, Helena Bonciani Nader, Nora Manoukian Forones, Leny Toma. Heparan Sulfate Proteoglycans in Human Colorectal Cancer. Analytical Cellular Pathology 2018; 2018: 1 doi: 10.1155/2018/8389595
|
| 93 |
M. Alexander, J. B. Burch, S. E. Steck, C.-F. Chen, T. G. Hurley, P. Cavicchia, N. Shivappa, J. Guess, H. Zhang, S. D. Youngstedt, K. E. Creek, S. Lloyd, K. Jones, J. R. Hébert. Case-control study of candidate gene methylation and adenomatous polyp formation. International Journal of Colorectal Disease 2017; 32(2): 183 doi: 10.1007/s00384-016-2688-1
|
| 94 |
Sheng Lu, Zheng-Gang Zhu, Wen-Cong Lu. Inferring novel genes related to colorectal cancer via random walk with restart algorithm. Gene Therapy 2019; 26(9): 373 doi: 10.1038/s41434-019-0090-7
|
| 95 |
Ssu-Ming Huang, Chingju Lin, Hsiao-Yun Lin, Chien-Ming Chiu, Chia-Wei Fang, Kuan-Fu Liao, Dar-Ren Chen, Wei-Lan Yeh. Brain-derived neurotrophic factor regulates cell motility in human colon cancer. Endocrine-Related Cancer 2015; 22(3): 455 doi: 10.1530/ERC-15-0007
|
| 96 |
Zhijin Li, Hua Tan, Hai Yu, Zhong Deng, Xiaobo Zhou, Maode Wang. DNA methylation and gene expression profiles characterize epigenetic regulation of lncRNAs in colon adenocarcinoma. Journal of Cellular Biochemistry 2020; 121(3): 2406 doi: 10.1002/jcb.29463
|
| 97 |
Yang Yang, Yanan Zhao, Nanjun Hu, Jia Zhao, Yuansong Bai. lncRNA KIAA0125 functions as a tumor suppressor modulating growth and metastasis of colorectal cancer via Wnt/β‐catenin pathway. Cell Biology International 2019; 43(12): 1463 doi: 10.1002/cbin.11196
|
| 98 |
Wen Pan, Yingying Cheng, Heyu Zhang, Baocai Liu, Xiaoning Mo, Ting Li, Lin Li, Xiaojing Cheng, Lianhai Zhang, Jiafu Ji, Pingzhang Wang, Wenling Han. CSBF/C10orf99, a novel potential cytokine, inhibits colon cancer cell growth through inducing G1 arrest. Scientific Reports 2014; 4(1) doi: 10.1038/srep06812
|
| 99 |
Ik Yong Kim. Impact of Microsatellite Instability in Signet-Ring Cell and Mucinous Components in Patients With Colorectal Carcinoma. Annals of Coloproctology 2016; 32(2): 45 doi: 10.3393/ac.2016.32.2.45
|
| 100 |
Jie Zhang, Kun Huang. Pan-cancer analysis of frequent DNA co-methylation patterns reveals consistent epigenetic landscape changes in multiple cancers. BMC Genomics 2017; 18(S1) doi: 10.1186/s12864-016-3259-0
|
| 101 |
Jingchun Qin, Bin Wen, Yuqi Liang, Weitao Yu, Huixuan Li. Histone Modifications and their Role in Colorectal Cancer (Review). Pathology & Oncology Research 2020; 26(4): 2023 doi: 10.1007/s12253-019-00663-8
|
| 102 |
Li Zhou, Zhe Shan, Jiangsha Fan. Extracellular Vesicles Derived from Human Bone Marrow Stem Cells Inhibit Acute Lymphoblastic Leukemia Cell Growth by Inhibiting MAPK Pathway via the miR-29b-3p/GDF15 Axis. Acta Haematologica 2023; 146(6): 504 doi: 10.1159/000527456
|
| 103 |
Hui Chang, Guan‐Nan Wang, Ya‐Lan Tao. The expression of long noncoding RNA CRCAL‐3 in colorectal cancer and its impacts on cell proliferation and migration. Journal of Cellular Biochemistry 2019; 120(9): 15369 doi: 10.1002/jcb.28804
|
| 104 |
Md. Shahadat Hossain, Mahafujul Islam Quadery Tonmoy, Md. Nur Islam, Md. Sajedul Islam, Ibrahim Khalil Afif, Arpita Singha Roy, Atqiya Fariha, Hasan Al Reza, Newaz Mohammed Bahadur, Md. Mizanur Rahaman. MicroRNAs expression analysis shows key affirmation of Synaptopodin-2 as a novel prognostic and therapeutic biomarker for colorectal and cervical cancers. Heliyon 2021; 7(6): e07347 doi: 10.1016/j.heliyon.2021.e07347
|
| 105 |
Fabio Coppedè, Angela Lopomo, Lucia Migliore. Personalized Epigenetics. 2015; : 183 doi: 10.1016/B978-0-12-420135-4.00007-3
|
| 106 |
Alessandra Cassana, Mario Abedrapo, Mauricio Diaz, Diego Zamorano, Alejandro Zárate. Tamizaje de cáncer colorrectal: pruebas emergentes no invasivas. Revista Médica Clínica Las Condes 2024; 35(2): 82 doi: 10.1016/j.rmclc.2024.03.006
|
| 107 |
Sara Pączek, Monika Zajkowska, Barbara Mroczko. Pigment Epithelial-Derived Factor in Pancreatic and Liver Cancers—From Inflammation to Cancer. Biomedicines 2024; 12(10): 2260 doi: 10.3390/biomedicines12102260
|
| 108 |
John M. Carethers. Fecal DNA Testing for Colorectal Cancer Screening. Annual Review of Medicine 2020; 71(1): 59 doi: 10.1146/annurev-med-103018-123125
|
| 109 |
Junhui Yu, Kui Yang, Jianbao Zheng, Pengwei Zhao, Jie Xia, Xuejun Sun, Wei Zhao. Activation of FXR and inhibition of EZH2 synergistically inhibit colorectal cancer through cooperatively accelerating FXR nuclear location and upregulating CDX2 expression. Cell Death & Disease 2022; 13(4) doi: 10.1038/s41419-022-04745-5
|
| 110 |
Nirmala Dushyanthi Sirisena, Kemal Deen, Dayupathi Eranda Nipunika Mandawala, Pumindu Herath, Vajira Harshadeva Weerabaddana Dissanayake. The pattern of KRAS mutations in metastatic colorectal cancer: a retrospective audit from Sri Lanka. BMC Research Notes 2017; 10(1) doi: 10.1186/s13104-017-2731-5
|
| 111 |
Renshen Xiang, Tao Fu. Gastrointestinal adenocarcinoma analysis identifies promoter methylation-based cancer subtypes and signatures. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-78228-y
|
| 112 |
Jessica M. Silva-Fisher, Ha X. Dang, Nicole M. White, Matthew S. Strand, Bradley A. Krasnick, Emily B. Rozycki, Gejae G. L. Jeffers, Julie G. Grossman, Maureen K. Highkin, Cynthia Tang, Christopher R. Cabanski, Abdallah Eteleeb, Jacqueline Mudd, S. Peter Goedegebuure, Jingqin Luo, Elaine R. Mardis, Richard K. Wilson, Timothy J. Ley, Albert C. Lockhart, Ryan C. Fields, Christopher A. Maher. Long non-coding RNA RAMS11 promotes metastatic colorectal cancer progression. Nature Communications 2020; 11(1) doi: 10.1038/s41467-020-15547-8
|
| 113 |
Ramón Cacabelos, Juan C. Carril, Ana Sanmartín, Pablo Cacabelos. Pharmacoepigenetics. 2019; : 191 doi: 10.1016/B978-0-12-813939-4.00006-1
|
| 114 |
Nuno Tiago Tavares, Saulė Gumauskaitė, João Lobo, Carmen Jerónimo, Rui Henrique. DNA Methylation Biomarkers for Prediction of Response to Platinum-Based Chemotherapy: Where Do We Stand?. Cancers 2022; 14(12): 2918 doi: 10.3390/cancers14122918
|
| 115 |
Ming Yi, Ruoqing Zhu, Robert M. Stephens, Sripathi M. Sureban. GradientScanSurv—An exhaustive association test method for gene expression data with censored survival outcome. PLOS ONE 2018; 13(12): e0207590 doi: 10.1371/journal.pone.0207590
|
| 116 |
Monika Stastna, Lucie Janeckova, Dusan Hrckulak, Vitezslav Kriz, Vladimir Korinek. Human Colorectal Cancer from the Perspective of Mouse Models. Genes 2019; 10(10): 788 doi: 10.3390/genes10100788
|
| 117 |
Wen-song Cai, Fei Shen, Zhe Feng, Ji-wei Chen, Qi-cai Liu, Er-mao Li, Bo Xu, Jie Cao. Downregulation of CDK-8 inhibits colon cancer hepatic metastasis by regulating Wnt/β-catenin pathway. Biomedicine & Pharmacotherapy 2015; 74: 153 doi: 10.1016/j.biopha.2015.08.015
|
| 118 |
Fabio Coppedè. Genes and the Environment in Cancer: Focus on Environmentally Induced DNA Methylation Changes. Cancers 2023; 15(4): 1019 doi: 10.3390/cancers15041019
|
| 119 |
Deborah Katharina Erhart, Veronika Klose, Tatjana Schäper, Hayrettin Tumani, Makbule Senel. CXCL13 in Cerebrospinal Fluid: Clinical Value in a Large Cross-Sectional Study. International Journal of Molecular Sciences 2023; 25(1): 425 doi: 10.3390/ijms25010425
|
| 120 |
Sung Noh Hong. Genetic and epigenetic alterations of colorectal cancer. Intestinal Research 2018; 16(3): 327 doi: 10.5217/ir.2018.16.3.327
|
| 121 |
Xingsheng Zuo, Haiguan Lin, ZhiYu Song, BingXin Yu, Chenglong Zhao. Antitumor activity of dictamnine against colorectal cancer through induction of ferroptosis and inhibition of M2 macrophage polarization via the MAPK signaling. Archives of Biochemistry and Biophysics 2024; 758: 110051 doi: 10.1016/j.abb.2024.110051
|
| 122 |
Siyu Zhou, Qian He, Nengquan Sheng, Jianfeng Gong, Jiazi Ren, Zhigang Wang. Blood cholesterol-to-lymphocyte ratio as a novel prognostic marker to predict postoperative overall survival in patients with colorectal cancer. World Journal of Surgical Oncology 2022; 20(1) doi: 10.1186/s12957-021-02471-4
|
| 123 |
Neelesh Kumar Yadav, Jitendra Bahadur Maurya. Bismuthene-Coated Fiber-Optic Plasmonic Sensor: Theoretical Foundation for the Experimental Detection of Human Colorectal Cancer. Plasmonics 2024; doi: 10.1007/s11468-024-02275-8
|
| 124 |
Sergei A. Koshkin, Olga V. Anatskaya, Alexander E. Vinogradov, Vladimir N. Uversky, Guy W. Dayhoff, Margarita A. Bystriakova, Valery A. Pospelov, Elena N. Tolkunova. Isolation and Characterization of Human Colon Adenocarcinoma Stem-Like Cells Based on the Endogenous Expression of the Stem Markers. International Journal of Molecular Sciences 2021; 22(9): 4682 doi: 10.3390/ijms22094682
|
| 125 |
Atena Soleimani, Mehran Pashirzad, Amir Avan, Gordon A. Ferns, Majid Khazaei, Seyed Mahdi Hassanian. Role of the transforming growth factor‐β signaling pathway in the pathogenesis of colorectal cancer. Journal of Cellular Biochemistry 2019; 120(6): 8899 doi: 10.1002/jcb.28331
|
| 126 |
Ming Bao, Shenglong Li, Yu Zhu, Xiaoyu Dong, Ran Wang, Fangyan Jing. CHL1 inhibits cell proliferation, migration and invasion by regulating the NF‑κB signaling pathway in colorectal cancer. Experimental and Therapeutic Medicine 2024; 27(4) doi: 10.3892/etm.2024.12454
|
| 127 |
Afaf Elsaid, Rami Elshazli, Fatma El-Tarapely, Hossam Darwish, Camelia Abdel-Malak. Association of monoallelic MUTYH mutation among Egyptian patients with colorectal cancer. Familial Cancer 2017; 16(1): 83 doi: 10.1007/s10689-016-9927-z
|
| 128 |
Shan Li, Zhengshui Xu, Jing Guo, Jianbao Zheng, Xuejun Sun, Junhui Yu. Farnesoid X receptor activation induces antitumour activity in colorectal cancer by suppressing JAK2/STAT3 signalling via transactivation of SOCS3 gene. Journal of Cellular and Molecular Medicine 2020; 24(24): 14549 doi: 10.1111/jcmm.16083
|
| 129 |
Yi-Sheng Xiao, Hua-Zhang Tong, Xi-Hong Yuan, Chang-Hui Xiong, Xiao-Yang Xu, Yuan-Feng Zeng. CircFADS2: A potential prognostic biomarker of colorectal cancer. Experimental Biology and Medicine 2020; 245(14): 1233 doi: 10.1177/1535370220929965
|
| 130 |
Katrin Pfütze, Axel Benner, Michael Hoffmeister, Lina Jansen, Rongxi Yang, Hendrik Bläker, Esther Herpel, Alexis Ulrich, Cornelia M. Ulrich, Jenny Chang-Claude, Hermann Brenner, Barbara Burwinkel. Methylation status at HYAL2 predicts overall and progression-free survival of colon cancer patients under 5-FU chemotherapy. Genomics 2015; 106(6): 348 doi: 10.1016/j.ygeno.2015.10.002
|
| 131 |
Mikhlid H. Almutairi, Waad A. Alsoraie, Turki M. Alrubie, Ahmad S. Alkhaldi, Nada S. Alhajri, Monira A. Alaujan, Manar H. Almutairi, Bader O. Almutairi. Increased MAGE-C Family Gene Expression Levels as a Biomarker of Colon Cancer Through the Demethylation Mechanism. Pharmaceuticals 2024; 17(11): 1447 doi: 10.3390/ph17111447
|
| 132 |
Sadaf Davudian, Neda Shajari, Tohid Kazemi, Behzad Mansoori, Shima Salehi, Ali Mohammadi, Dariush Shanehbandi, Vahid Khaze Shahgoli, Milad Asadi, Behzad Baradaran. BACH1 silencing by siRNA inhibits migration of HT-29 colon cancer cells through reduction of metastasis-related genes. Biomedicine & Pharmacotherapy 2016; 84: 191 doi: 10.1016/j.biopha.2016.09.021
|
| 133 |
Jessica S. Thomas, Chanjuan Shi. Diagnostic Molecular Pathology. 2024; : 339 doi: 10.1016/B978-0-12-822824-1.00018-3
|
| 134 |
Jingtian Liu, Zongyou Chen, Jianbin Xiang, Xiaodong Gu. MicroRNA-155 acts as a tumor suppressor in colorectal cancer by targeting CTHRC1 in�vitro. Oncology Letters 2018; doi: 10.3892/ol.2018.8069
|
| 135 |
Junhui Yu, Shan Li, Jing Guo, Zhengshui Xu, Jianbao Zheng, Xuejun Sun. Farnesoid X receptor antagonizes Wnt/β-catenin signaling in colorectal tumorigenesis. Cell Death & Disease 2020; 11(8) doi: 10.1038/s41419-020-02819-w
|
| 136 |
Yuan-Feng Zeng, Yi-Sheng Xiao, Ming-Zhi Lu, Xiao-Jiang Luo, Guo-Zhu Hu, Ke-Yu Deng, Xiao-Mu Wu, Hong-Bo Xin. Increased expression of formin-like 3 contributes to metastasis and poor prognosis in colorectal carcinoma. Experimental and Molecular Pathology 2015; 98(2): 260 doi: 10.1016/j.yexmp.2015.03.008
|
| 137 |
|
| 138 |
Wei Zhu, Yan Si, Jun Xu, Yu Lin, Jing‐Zi Wang, Mengda Cao, Shanwen Sun, Qiang Ding, Lingjun Zhu, Ji‐Fu Wei. Methyltransferase like 3 promotes colorectal cancer proliferation by stabilizing CCNE1 mRNA in an m6A‐dependent manner. Journal of Cellular and Molecular Medicine 2020; 24(6): 3521 doi: 10.1111/jcmm.15042
|
| 139 |
Huimin Zhou, Yiming Zhang, Qikui Chen, Ying Lin. AKT and JNK Signaling Pathways Increase the Metastatic Potential of Colorectal Cancer Cells by Altering Transgelin Expression. Digestive Diseases and Sciences 2016; 61(4): 1091 doi: 10.1007/s10620-015-3985-1
|
| 140 |
SURASAK SANGKHATHAT, WANWISA MANEECHAY, WELAWEE CHAIYAPAN, SAMORNMAS KANNGERN, TEERANUT BOONPIPATTANAPONG. Association of Wilms' tumor 1 gene single-nucleotide polymorphism rs16754 with colorectal cancer. Molecular and Clinical Oncology 2015; 3(6): 1401 doi: 10.3892/mco.2015.647
|
| 141 |
Qiong Duan, Bin-Hui Chen, Yi Lin. Down-regulation of ClC-3 enhances chemosensitivity of colorectal cancer cells to oxaliplatin by inhibiting autophagy. World Chinese Journal of Digestology 2020; 28(24): 1235 doi: 10.11569/wcjd.v28.i24.1235
|
| 142 |
Fuguo Liu, Fengzhi Ji, Yuling Ji, Yueping Jiang, Xueguo Sun, Yanyan Lu, Lingyun Zhang, Yue Han, Xishuang Liu. Dissecting the mechanism of colorectal tumorigenesis based on RNA-sequencing data. Experimental and Molecular Pathology 2015; 98(2): 246 doi: 10.1016/j.yexmp.2015.01.004
|
| 143 |
Hong-Li Jiao, Ya-Ping Ye, Run-Wei Yang, Hui-Ying Sun, Shu-Yang Wang, Yong-Xia Wang, Zhi-Yuan Xiao, Liu-Qing He, Juan-Juan Cai, Wen-Ting Wei, Yan-Ru Chen, Chun-Cai Gu, Yue-Long Cai, Yun-Teng Hu, Qiu-Hua Lai, Jun-Feng Qiu, Li Liang, Guang-Wen Cao, Wen-Ting Liao, Yan-Qing Ding. Downregulation of SAFB Sustains the NF-κB Pathway by Targeting TAK1 during the Progression of Colorectal Cancer. Clinical Cancer Research 2017; 23(22): 7108 doi: 10.1158/1078-0432.CCR-17-0747
|
| 144 |
Fabio Tordini, Marco Aldinucci, Luciano Milanesi, Pietro Liò, Ivan Merelli. The Genome Conformation As an Integrator of Multi-Omic Data: The Example of Damage Spreading in Cancer. Frontiers in Genetics 2016; 7 doi: 10.3389/fgene.2016.00194
|
| 145 |
Mi Zhou, Hongyun Huang, Deying Bao, Meining Chen, Fulin Lu. Assessment of prognostic indicators and KRAS mutations in rectal cancer using a fractional-order calculus MR diffusion model: whole tumor histogram analysis. Abdominal Radiology 2024; doi: 10.1007/s00261-024-04523-1
|
| 146 |
Dongzhi Cen, Li Xu, Siwei Zhang, Zhiguang Chen, Yan Huang, Ziqi Li, Bo Liang. Renal cell carcinoma: predicting RUNX3 methylation level and its consequences on survival with CT features. European Radiology 2019; 29(10): 5415 doi: 10.1007/s00330-019-06049-3
|
| 147 |
Andrea Iannone, Giuseppe Losurdo, Maria Pricci, Bruna Girardi, Antonio Massaro, Mariabeatrice Principi, Michele Barone, Enzo Ierardi, Alfredo Di Leo. Stool Investigations for Colorectal Cancer Screening: From Occult Blood Test to DNA Analysis. Journal of Gastrointestinal Cancer 2016; 47(2): 143 doi: 10.1007/s12029-016-9810-z
|
| 148 |
Jie Zhong, Ranran Pan, Xiuru Ying, Boyi Wu, Cong Zhou, Dongping Wu, Jieer Ying, Shiwei Duan. Significant association between KDM1A promoter hypomethylation and colorectal cancer in Han Chinese. Pathology - Research and Practice 2019; 215(3): 532 doi: 10.1016/j.prp.2018.12.005
|
| 149 |
Qin Dang, Lulu Zuo, Xinru Hu, Zhaokai Zhou, Shuang Chen, Shutong Liu, Yuhao Ba, Anning Zuo, Hui Xu, Siyuan Weng, Yuyuan Zhang, Peng Luo, Quan Cheng, Zaoqu Liu, Xinwei Han. Molecular subtypes of colorectal cancer in the era of precision oncotherapy: Current inspirations and future challenges. Cancer Medicine 2024; 13(14) doi: 10.1002/cam4.70041
|
| 150 |
Maria Beatriz de Matos, Laura Elisabete Barbosa, João Paulo Teixeira. Narrative review comparing the epidemiology, characteristics, and survival in sporadic colorectal carcinoma/Lynch syndrome. Journal of Coloproctology 2020; 40(01): 073 doi: 10.1016/j.jcol.2019.07.006
|
| 151 |
Leticia Moreira, Francesc Balaguer, Ajay Goel. Intestinal Tumorigenesis. 2015; : 137 doi: 10.1007/978-3-319-19986-3_5
|
| 152 |
Anamitra Majumdar, Jigar Lad, Kseniia Tumanova, Stefano Serra, Fayez Quereshy, Mohammadali Khorasani, Alex Vitkin. Machine learning based local recurrence prediction in colorectal cancer using polarized light imaging. Journal of Biomedical Optics 2023; 29(05) doi: 10.1117/1.JBO.29.5.052915
|
| 153 |
Eirini Tsirvouli, Vasundra Touré, Barbara Niederdorfer, Miguel Vázquez, Åsmund Flobak, Martin Kuiper. A Middle-Out Modeling Strategy to Extend a Colon Cancer Logical Model Improves Drug Synergy Predictions in Epithelial-Derived Cancer Cell Lines. Frontiers in Molecular Biosciences 2020; 7 doi: 10.3389/fmolb.2020.502573
|
| 154 |
Ilaria Marech, Michele Ammendola, Rosario Sacco, Giuseppe Sammarco, Valeria Zuccalà, Nicola Zizzo, Christian Leporini, Maria Luposella, Rosa Patruno, Gianfranco Filippelli, Emilio Russo, Mariangela Porcelli, Cosmo Damiano Gadaleta, Giovambattista De Sarro, Girolamo Ranieri. Tumour‐associated macrophages correlate with microvascular bed extension in colorectal cancer patients. Journal of Cellular and Molecular Medicine 2016; 20(7): 1373 doi: 10.1111/jcmm.12826
|
| 155 |
Yaojun Peng, Jing Zhao, Fan Yin, Gaowa Sharen, Qiyan Wu, Qi Chen, Xiaoxuan Sun, Juan Yang, Huan Wang, Dong Zhang. A methylation‐driven gene panel predicts survival in patients with colon cancer. FEBS Open Bio 2021; 11(9): 2490 doi: 10.1002/2211-5463.13242
|
| 156 |
Tharmini Rathinagopal, Shiv Bhanot, Sergey Yegrov, Jordan Min, Nan Hu, John Fang, Tom H. Greene, Shailly Varma Shrivastav, Harminder Singh, Anuraag Shrivastav. N-myristoyltransferase 2–based Blood Test for the Detection of Colorectal Adenomatous Polyps and Cancer. Annals of Surgery Open 2022; 3(1): e117 doi: 10.1097/AS9.0000000000000117
|
| 157 |
Jingde Chen, Li Li, Zhuqing Zhou, Shijun Yu, Yandong Li, Yong Gao. FAPP2 promotes tumor cell growth in human colon cancer through activation of Wnt signaling. Experimental Cell Research 2019; 374(1): 12 doi: 10.1016/j.yexcr.2018.11.002
|
| 158 |
Cong-Min Zhang, Jin-Feng Lv, Liang Gong, Lin-Yu Yu, Xiao-Ping Chen, Hong-Hao Zhou, Lan Fan. Role of Deficient Mismatch Repair in the Personalized Management of Colorectal Cancer. International Journal of Environmental Research and Public Health 2016; 13(9): 892 doi: 10.3390/ijerph13090892
|
| 159 |
Farzad Rahmani, Amir Avan, Seyed Isaac Hashemy, Seyed Mahdi Hassanian. Role of Wnt/β‐catenin signaling regulatory microRNAs in the pathogenesis of colorectal cancer. Journal of Cellular Physiology 2018; 233(2): 811 doi: 10.1002/jcp.25897
|
| 160 |
Alvaro Mordente, Elisabetta Meucci, Giuseppe Ettore Martorana, Andrea Silvestrini. Advances in Cancer Biomarkers. Advances in Experimental Medicine and Biology 2015; 867: 9 doi: 10.1007/978-94-017-7215-0_2
|
| 161 |
Sandra Mersakova, Katarina Janikova, Michal Kalman, Juraj Marcinek, Marian Grendar, Martin Vojtko, Roman Kycina, Miroslav Pindura, Jan Janik, Peter Mikolajcik, Eva Gabonova, Ludovit Laca, Ester Mejstrikova, Erika Halasova, Jan Strnadel, Zora Lasabova. Cancer stem cell marker expression and methylation status in patients with colorectal cancer. Oncology Letters 2022; 24(1) doi: 10.3892/ol.2022.13352
|
| 162 |
Sholeh Ghaedamini, Mehdi Nikbakht, Mitra Soleimani. Assessment of Immuno-Histochemical Expression of MBD1 in Colorectal Adenocarcinoma and Its Correlations with Prognostic Factors. Middle East Journal of Digestive Diseases 2019; 12(1): 39 doi: 10.15171/mejdd.2020.162
|
| 163 |
Emma Minnee, William James Faller. Translation initiation and its relevance in colorectal cancer. The FEBS Journal 2021; 288(23): 6635 doi: 10.1111/febs.15690
|
| 164 |
V. V. Vereshchak, I. N. Iurichev, A. O. Rasulov, J. M. Madyarov. Noninvasive colorectal cancer screening techniques: literature review. MD-Onco 2023; 3(3): 57 doi: 10.17650/2782-3202-2023-3-3-57-63
|
| 165 |
Nasimeh Vatandoost, Jahanafrooz Ghanbari, Mahboobeh Mojaver, Amir Avan, Majid Ghayour-Mobarhan, Reza Nedaeinia, Rasoul Salehi. Early detection of colorectal cancer: from conventional methods to novel biomarkers. Journal of Cancer Research and Clinical Oncology 2016; 142(2): 341 doi: 10.1007/s00432-015-1928-z
|
| 166 |
Eun Ran Kim, Young-Ho Kim. Clinical Application of Genetics in Management of Colorectal Cancer. Intestinal Research 2014; 12(3): 184 doi: 10.5217/ir.2014.12.3.184
|
| 167 |
Haochang Hu, Xiaoying Chen, Cheng Wang, Yuting Jiang, Jingjing Li, Xiuru Ying, Yong Yang, Bin Li, Cong Zhou, Jie Zhong, Dongping Wu, Jieer Ying, Shiwei Duan. The role of TFPI2 hypermethylation in the detection of gastric and colorectal cancer. Oncotarget 2017; 8(48): 84054 doi: 10.18632/oncotarget.21097
|
| 168 |
Xinkui Liu, Jiarui Wu, Dan Zhang, Kaihuan Wang, Xiaojiao Duan, Xiaomeng Zhang, Jae Youl Cho. A Network Pharmacology Approach to Uncover the Multiple Mechanisms of Hedyotis diffusa Willd. on Colorectal Cancer. Evidence-Based Complementary and Alternative Medicine 2018; 2018(1) doi: 10.1155/2018/6517034
|
| 169 |
Mami Kaneko, Masanori Kotake, Hiroyuki Bando, Tetsuji Yamada, Hirofumi Takemura, Toshinari Minamoto. Prognostic and predictive significance of long interspersed nucleotide element-1 methylation in advanced-stage colorectal cancer. BMC Cancer 2016; 16(1) doi: 10.1186/s12885-016-2984-8
|
| 170 |
Seyed Mostafa Parizadeh, Reza Jafarzadeh-Esfehani, Seyed Mahdi Hassanian, Seyed Mohammad Reza Parizadeh, Samaneh Vojdani, Maryam Ghandehari, Anahita Ghazaghi, Majid Khazaei, Soodabeh Shahidsales, Majid Rezayi, Fereshteh Asgharzadeh, Majid Ghayour-Mobarhan, Gordon A. Ferns, Amir Avan. Targeting cancer stem cells as therapeutic approach in the treatment of colorectal cancer. The International Journal of Biochemistry & Cell Biology 2019; 110: 75 doi: 10.1016/j.biocel.2019.02.010
|
| 171 |
Jie Wu, Guangchuan Wang, Baojun He, Xuejun Chen, Yuzhi An. Methylation of the UNC5C gene and its protein expression in colorectal cancer. Tumor Biology 2017; 39(4): 101042831769756 doi: 10.1177/1010428317697564
|
| 172 |
Jinhua He, Feifeng Wu, Zeping Han, Min Hu, Weida Lin, Yuguang Li, Mingrong Cao. Biomarkers (mRNAs and Non-Coding RNAs) for the Diagnosis and Prognosis of Colorectal Cancer – From the Body Fluid to Tissue Level. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.632834
|
| 173 |
Suliman Y. Al Omar, Lamjed Mansour, Javid Ahmed Dar, Saleh Alwasel, Afrah Alkhuriji, Maha Arafah, Omar Al Obeed, Stephen Christmas. The Relationship Between Killer Cell Immunoglobulin-Like Receptors and HLA-C Polymorphisms in Colorectal Cancer in a Saudi Population. Genetic Testing and Molecular Biomarkers 2015; 19(11): 617 doi: 10.1089/gtmb.2015.0105
|
| 174 |
Mansour K. Gatasheh, Sathan Raj Natarajan, Rajapandiyan Krishnamoorthy, Tawfiq S Alsulami, Ponnulakshmi Rajagopal, Chella Perumal Palanisamy, Vishnu Priya Veeraraghavan, Selvaraj Jayaraman. Molecular analysis to identify novel potential biomarkers as drug targets in colorectal cancer therapy: an integrated bioinformatics analysis. Molecular & Cellular Oncology 2024; 11(1) doi: 10.1080/23723556.2024.2326699
|
| 175 |
Michele Ammendola, Rosa Patruno, Rosario Sacco, Ilaria Marech, Giuseppe Sammarco, Valeria Zuccalà, Maria Luposella, Nicola Zizzo, Claudia Gadaleta, Mariangela Porcelli, Cosmo Damiano Gadaleta, Domenico Ribatti, Girolamo Ranieri. Mast cells positive to tryptase and tumour-associated macrophages correlate with angiogenesis in locally advanced colorectal cancer patients undergone to surgery. Expert Opinion on Therapeutic Targets 2016; 20(5): 533 doi: 10.1517/14728222.2016.1158811
|
| 176 |
Ying Zhang, Lu Guo, Yuhuan Li, Gui-Hai Feng, Fei Teng, Wei Li, Qi Zhou. MicroRNA-494 promotes cancer progression and targets adenomatous polyposis coli in colorectal cancer. Molecular Cancer 2018; 17(1) doi: 10.1186/s12943-017-0753-1
|
| 177 |
Hyunsung Kim, Abdul Rehman, Yumin Chung, Kijong Yi, Young Chan Wi, Yeseul Kim, Kiseok Jang, Se Min Jang, Seung Sam Paik. Clinicopathologic Significance of Extranodal Tumor Extension in Colorectal Adenocarcinoma with Regional Lymph Node Metastasis. Gastroenterology Research and Practice 2016; 2016: 1 doi: 10.1155/2016/5620765
|
| 178 |
Andrea Stoccoro, Fabio Coppedè, Lucia Migliore. Personalized Epigenetics. 2024; : 147 doi: 10.1016/B978-0-443-23802-4.00018-1
|
| 179 |
Pavel Hurník, Zuzana Chyra, Tereza Ševčíková, Jan Štembírek, Kateřina Smešný Trtková, Daria A. Gaykalova, Marcela Buchtová, Eva Hrubá. Epigenetic Regulations of Perineural Invasion in Head and Neck Squamous Cell Carcinoma. Frontiers in Genetics 2022; 13 doi: 10.3389/fgene.2022.848557
|
| 180 |
Minhong Shen, Shanshan Xie, Michelle Rowicki, Sven Michel, Yong Wei, Xiang Hang, Liling Wan, Xin Lu, Min Yuan, John F. Jin, Frank Jaschinski, Tianhua Zhou, Richard Klar, Yibin Kang. Therapeutic Targeting of Metadherin Suppresses Colorectal and Lung Cancer Progression and Metastasis. Cancer Research 2021; 81(4): 1014 doi: 10.1158/0008-5472.CAN-20-1876
|
| 181 |
Wataru Okajima, Shuhei Komatsu, Daisuke Ichikawa, Mahito Miyamae, Takuma Ohashi, Taisuke Imamura, Jun Kiuchi, Keiji Nishibeppu, Tomohiro Arita, Hirotaka Konishi, Atsushi Shiozaki, Ryo Morimura, Hisashi Ikoma, Kazuma Okamoto, Eigo Otsuji. Liquid biopsy in patients with hepatocellular carcinoma: Circulating tumor cells and cell-free nucleic acids. World Journal of Gastroenterology 2017; 23(31): 5650-5668 doi: 10.3748/wjg.v23.i31.5650
|
| 182 |
Tomasz Sawicki, Monika Ruszkowska, Anna Danielewicz, Ewa Niedźwiedzka, Tomasz Arłukowicz, Katarzyna E. Przybyłowicz. A Review of Colorectal Cancer in Terms of Epidemiology, Risk Factors, Development, Symptoms and Diagnosis. Cancers 2021; 13(9): 2025 doi: 10.3390/cancers13092025
|
| 183 |
Maria Anna Smolle, Martin Pichler, Johannes Haybaeck, Armin Gerger. Genetic Markers of Recurrence in Colorectal Cancer. Pharmacogenomics 2015; 16(11): 1313 doi: 10.2217/pgs.15.83
|
| 184 |
Koroush Ghanadi, Bahareh Shayanrad, Seyyed Amir Yasin Ahmadi, Farhad Shahsavar, Hossein Eliasy. Colorectal cancer and the KIR genes in the human genome: A meta-analysis. Genomics Data 2016; 10: 118 doi: 10.1016/j.gdata.2016.10.010
|
| 185 |
Michela Falco, Giuseppe Palma, Domenica Rea, Davide De Biase, Stefania Scala, Massimiliano D'Aiuto, Gaetano Facchini, Sisto Perdonà, Antonio Barbieri, Claudio Arra. Tumour biomarkers: homeostasis as a novel prognostic indicator. Open Biology 2016; 6(12): 160254 doi: 10.1098/rsob.160254
|
| 186 |
Aldona Kasprzak. Prognostic Biomarkers of Cell Proliferation in Colorectal Cancer (CRC): From Immunohistochemistry to Molecular Biology Techniques. Cancers 2023; 15(18): 4570 doi: 10.3390/cancers15184570
|
| 187 |
Sarina Almasi, Lida Haghnazari, Seyedeh Ozra Hosseini, Nayebali Rezvani. Detection of caudal type homeobox 1 (CDX1) gene methylated DNA, as a stool-based diagnostic biomarker in colorectal cancer. Journal of Genetics 2024; 103(2) doi: 10.1007/s12041-024-01473-x
|
| 188 |
Shibnath Ghatak, Vincent C. Hascall, Nikos Karamanos, Roger R. Markwald, Suniti Misra. Interplay Between Chemotherapy-Activated Cancer Associated Fibroblasts and Cancer Initiating Cells Expressing CD44v6 Promotes Colon Cancer Resistance. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.906415
|
| 189 |
Jennifer Quinchia, Danilo Echeverri, Andrés Cruz-Pacheco, María Maldonado, Jahir Orozco. Electrochemical Biosensors for Determination of Colorectal Tumor Biomarkers. Micromachines 2020; 11(4): 411 doi: 10.3390/mi11040411
|
| 190 |
Marco Vacante, Antonio Maria Borzì, Francesco Basile, Antonio Biondi. Biomarkers in colorectal cancer: Current clinical utility and future perspectives. World Journal of Clinical Cases 2018; 6(15): 869-881 doi: 10.12998/wjcc.v6.i15.869
|
| 191 |
Fahimeh Fattahi, Jafar Kiani, Mohsen Khosravi, Somayeh Vafaei, Asghar Mohammadi, Zahra Madjd, Mohammad Najafi. Enrichment of Up-regulated and Down-regulated Gene Clusters Using Gene Ontology, miRNAs and lncRNAs in Colorectal Cancer. Combinatorial Chemistry & High Throughput Screening 2019; 22(8): 534 doi: 10.2174/1386207321666191010114149
|
| 192 |
Xuan Zhang, Tao Wu, Rujia Qin, Xinyi Cai, Yongchun Zhou, Xiaoxiong Wang, Zhongjun Shang, Guoyu Li, Renfang Yang, Chao Dong, Jinsha Li, Yongping Ren, Rong Ding, Yunfeng Li. The New Role of HNF1A-NAS1/miR-214/INHBA Signaling Axis in Colorectal Cancer. Frontiers in Bioscience-Landmark 2023; 28(11) doi: 10.31083/j.fbl2811301
|
| 193 |
Tao He, Jie Cui, Yunhua Wu, Xuejun Sun, Nanzheng Chen. Knockdown of TRIM66 inhibits cell proliferation, migration and invasion in colorectal cancer through JAK2/STAT3 pathway. Life Sciences 2019; 235: 116799 doi: 10.1016/j.lfs.2019.116799
|
| 194 |
Hyung-Hoon Oh, Young-Eun Joo. Novel biomarkers for the diagnosis and prognosis of colorectal cancer. Intestinal Research 2020; 18(2): 168 doi: 10.5217/ir.2019.00080
|
| 195 |
|
| 196 |
Nikolai A. Ognerubov, Elena N. Ezhova. Somatic mutations in colorectal cancer: regional experience. Consilium Medicum 2022; 24(5): 291 doi: 10.26442/20751753.2022.5.201796
|
| 197 |
Yuan Feng, Jun Xia, Xin Xu, Tong Zhao, Zhengzhi Tan, Qun Wang, Jun Wang, Jia Meng, Christopher Sanderson, Zhiliang Lu, Yili Yang. Sesquiterpene lactone Bigelovin induces apoptosis of colon cancer cells through inducing IKK-β degradation and suppressing nuclear factor kappa B activation. Anti-Cancer Drugs 2021; 32(6): 664 doi: 10.1097/CAD.0000000000001073
|
| 198 |
Chang Su, Dong‑Ping Huang, Jian‑Wen Liu, Wei‑Yan Liu, Yi‑Ou Cao. miR‑27a‑3p regulates proliferation and apoptosis of colon cancer cells by potentially targeting BTG1. Oncology Letters 2019; doi: 10.3892/ol.2019.10629
|
| 199 |
Petros Christakis Papagiorgis. Segmental distribution of some common molecular markers for colorectal cancer (CRC): influencing factors and potential implications. Tumor Biology 2016; 37(5): 5727 doi: 10.1007/s13277-016-4913-5
|
| 200 |
Ben Li, Shanglong Liu, Yuan Gao, Longbo Zheng, Yun Lu. Combined detection of SDC2/ADHFE1/PPP2R5C methylation in stool DNA for colorectal cancer screening. Journal of Cancer Research and Clinical Oncology 2023; 149(12): 10241 doi: 10.1007/s00432-023-04943-4
|
| 201 |
Pinelopi I. Artemaki, Aimilia D. Sklirou, Christos K. Kontos, Aikaterini-Anna Liosi, Despoina D. Gianniou, Iordanis N. Papadopoulos, Ioannis P. Trougakos, Andreas Scorilas. High clusterin (CLU) mRNA expression levels in tumors of colorectal cancer patients predict a poor prognostic outcome. Clinical Biochemistry 2020; 75: 62 doi: 10.1016/j.clinbiochem.2019.10.008
|